Jan Orwar

Jan Orwar

Direttore/Membro del Consiglio presso FLUICELL AB
62 anni
Consumer Services
Commercial Services
Health Technology

Profilo

Jan Owe Owesson Orwar was the founder of Cellectricon AB, founded in 2000, where the title held was Director & Chief Scientific Officer.
Dr. Orwar is the founder of Nanoxis AB, founded in 2002, where the title held was Director & Chief Scientific Advisor from 2002 to 2014.
Dr. Orwar is also the founder of Oblique Therapeutics AB. Dr. Orwar is currently Director-Bioeletronics & Bio-Computing Program at Chalmers University of Technology since 2011.
Dr. Orwar is currently Director at Fluicell AB since 2015.
Dr. Orwar is currently Senior Group Leader at Karolinska Institutet.
Former positions include President-Research & Development at Piramal Enterprises Ltd. and Global Vice President-Research & Development at Sanofi AB. Education includes doctorates from Stanford University and the University of Gothenburg.

Posizioni attive di Jan Orwar

SocietàPosizioneInizio
FLUICELL AB Direttore/Membro del Consiglio 01/01/2015
Corporate Officer/Principal 17/01/2011
Corporate Officer/Principal -

Precedenti posizioni note di Jan Orwar

SocietàPosizioneFine
Fondatore 11/02/2014
PIRML ENT Direttore Tecnico/Scientifico/R&S -
Direttore Tecnico/Scientifico/R&S -
Amministratore Delegato -
Fondatore -
Vedi nel dettaglio l'esperienza di Jan Orwar

Formazione di Jan Orwar

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

93

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Commercial Services

Consumer Services

Finance

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Distribution Services

Health Technology